NVDA
59
7
OKE
58
3
FAST
59
-4
ISRG
71
5
BBY
48
3
CHRW
59
-3
AIV
39
-2
MTB
52
-11
BF.B
48
-5
PFE
23
2
BWA
49
-4
SE
80
8
PWR
75
4
DNB
72
4
SHW
61
11
NWSA
78
3
KMI
57
2
KMB
39
11
SO
59
2
TDC
44
3
NVDA
59
7
OKE
58
3
FAST
59
-4
ISRG
71
5
BBY
48
3
CHRW
59
-3
AIV
39
-2
MTB
52
-11
BF.B
48
-5
PFE
23
2
BWA
49
-4
SE
80
8
PWR
75
4
DNB
72
4
SHW
61
11
NWSA
78
3
KMI
57
2
KMB
39
11
SO
59
2
TDC
44
3
Financhill
Back

Enliven Therapeutics Stock Predictions

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
34

ELVN
Enliven Therapeutics

Last Price:
$18.12
Seasonality Move:
1.57%

7 Day Trial

ALL ACCESS PASS

$ 7

Enliven Therapeutics Stock Forecast

  • Over the next 52 weeks, Enliven Therapeutics has on average historically risen by 20.3% based on the past 5 years of stock performance.
  • Enliven Therapeutics has risen higher in 2 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 40%
  • Is Enliven Therapeutics Stock Undervalued?
    The current Enliven Therapeutics [ELVN] share price is $18.21. The Score for ELVN is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
  • ELVN is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.

Will Enliven Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, Enliven Therapeutics has on average historically risen by 20.3% based on the past 5 years of stock performance.

Enliven Therapeutics Stock Rating

Sell
34
Enliven Therapeutics (ELVN) is a Sell

Is Enliven Therapeutics overpriced?

  • Enliven Therapeutics has risen higher in 2 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 40%

Enliven Therapeutics Stock Price History

Is ELVN stock going to rise?

  • The current trend is relatively stagnant and ELVN is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
enliventherapeutics.com

52-Week Data

52-Week High:
30.03
52-Week Low:
13.30

Prediction Charts

Market Cap:
892.4M
Price in USD:
18.21
Volume:
125K
Beta:
0.93

Technical Analysis

SMA50:
19.69
SMA100:
21.21
SMA200:
23.07
52-Wk Change:
8.52%

Stock Predictions

  • Is Enliven Therapeutics stock public?
    Yes, Enliven Therapeutics is a publicly traded company.
  • What is the Enliven Therapeutics stock quote today?
    The Enliven Therapeutics stock price is 18.21 USD today.
  • How to buy Enliven Therapeutics stock online?
    You can buy Enliven Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Apr-7 18.00 17.87 19.69 16.99
Apr-8 18.49 15.82 18.76 15.14
Apr-9 15.43 16.52 17.19 14.47
Apr-10 15.53 14.91 15.72 13.30
Apr-11 15.06 16.51 16.54 14.45
Apr-14 17.06 17.19 17.38 16.30
Apr-15 17.17 17.05 18.14 16.38
Apr-16 16.92 16.07 17.37 15.49
Apr-17 16.12 16.53 16.85 16.07
Apr-21 16.15 16.22 16.82 15.44
Apr-22 16.45 17.97 18.23 16.45
Apr-23 18.65 17.77 19.61 17.71
Apr-24 17.72 18.30 18.57 17.36
Apr-25 18.05 18.21 18.40 17.46

Enliven Therapeutics Earnings

Enliven Therapeutics Earnings Report: Per Share Enliven Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Enliven Therapeutics Forecast Revenue Growth

Enliven Therapeutics Stock Analysis: Historical quarterly revenues per share for Enliven Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.55 per share, and a decrease next year of $0.60 per share.

* Enliven Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.